The CEO Behind Kimberly-Clark’s $40 Billion Gamble on Tylenol Maker

Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Kimberly-Clark to buy maker of Tylenol in $48.7 billion cash-and-stock deal

Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...
Dallas Morning News

Kimberly-Clark picks Michael Hsu to lead the consumer products company

Kleenex tissues are a Kimberly-Clark brand. Just over half of the company’s revenue comes from outside North America. File 2011 / FThe Associated Press Michael Hsu will succeed Thomas Falk as chief ...

Kimberly-Clark bets $40 billion for Kenvue despite Tylenol controversy

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...